129 related articles for article (PubMed ID: 2576667)
1. Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study.
Ambrosioni E; Birkenhäger W; De Leeuw PW; Dal Palù C; Demanet JC; Groothold G; Libretti A; Mailland F; Malacco E; Poli A
J Hypertens Suppl; 1989 Dec; 7(6):S266-7. PubMed ID: 2576667
[TBL] [Abstract][Full Text] [Related]
2. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
Young PH
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S82-5. PubMed ID: 1378155
[TBL] [Abstract][Full Text] [Related]
3. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
5. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
[TBL] [Abstract][Full Text] [Related]
6. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
7. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
Malacco E; Mailland F; Bosisio E; Meroni R; Dagani R; Renesto E; Bevilacqua M
Eur J Clin Pharmacol; 1986; 30(2):157-60. PubMed ID: 3709639
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
Bühler FR; Berglund G; Anderson OK; Brunner HR; Scherrer U; van Brummelen P; Distler A; Philipp T; Fogari R; Mimran A
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S122-7. PubMed ID: 2439782
[TBL] [Abstract][Full Text] [Related]
10. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
van Zyl AI; Jennings AA; Bateman ED; Opie LH
Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.
Eriksson JW; Jansson PA; Foley K; Lithell H
J Hypertens; 1996 Dec; 14(12):1469-75. PubMed ID: 8986932
[TBL] [Abstract][Full Text] [Related]
12. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
Widmann L; van der Does R; Hörrmann M; Machwirth M
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
[TBL] [Abstract][Full Text] [Related]
13. Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.
Salvadeo A; Villa G; Segagni S; Piazza V; Picardi L; Romano M; Parini J
Arzneimittelforschung; 1985; 35(3):623-5. PubMed ID: 2859865
[TBL] [Abstract][Full Text] [Related]
14. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
15. [Potential use of indenolol in hypertensive patients with chronic bronchial asthma].
Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Palazzo F; Scappaticci E
Minerva Med; 1986 Oct; 77(39):1819-21. PubMed ID: 3534631
[TBL] [Abstract][Full Text] [Related]
16. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
[TBL] [Abstract][Full Text] [Related]
17. Indenolol in hypertension.
Sega R; Mailland F; Damiani E; Groothold G; Libretti A
Clin Pharmacol Ther; 1983 Mar; 33(3):289-93. PubMed ID: 6337761
[TBL] [Abstract][Full Text] [Related]
18. Influence of salt intake on the antihypertensive effect of carvedilol.
Ruilope LM; Lahera V
J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
[TBL] [Abstract][Full Text] [Related]
19. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
Sau F; Seguro C; Lai C; Orani E; Soro A; Onnis E; Cherchi A
Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
[TBL] [Abstract][Full Text] [Related]
20. Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control.
Diabetologia; 1996 Dec; 39(12):1554-61. PubMed ID: 8960842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]